The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy

(2012) F. Longo et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2011) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy

(2011) Jason M. Jones et al.   JOURNAL OF PALLIATIVE MEDICINE

Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice

(2011) Suthinee Ithimakin et al.   SUPPORTIVE CARE IN CANCER

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

(2010) F. Roila et al.   ANNALS OF ONCOLOGY

Reduced Ghrelin Secretion in the Hypothalamus of Rats due to Cisplatin-Induced Anorexia

(2010) Koji Yakabi et al.   ENDOCRINOLOGY

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer

(2010) Rudolph M Navari   Future Oncology

Aprepitant

(2009) Monique P. Curran et al.   DRUGS

Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting

(2009) Rudolph M. Navari   DRUGS

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

(2009) Kamalesh K Sankhala et al.   Expert Opinion on Drug Metabolism & Toxicology

Whole brain radiotherapy with radiosensitizer for brain metastases

(2009) Gustavo Viani et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH